Skip to content

Drug interactions

Dasatinib + Desogestrel-ethinyl estradiol

Severity: Minor

Dasatinib and Desogestrel-ethinyl estradiol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dasatinib is a CYP3A4 substrate and ethinyl estradiol is a weak CYP3A4 inhibitor, so a small rise in dasatinib exposure is conceivable. Clinical significance is likely modest. Dasatinib is also teratogenic, so reliable contraception remains important.

What this interaction means in plain words

Dasatinib and Desogestrel-ethinyl estradiol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dasatinib belongs to Oncology; Desogestrel-ethinyl estradiol belongs to Endocrine.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by ethinyl estradiol may slightly reduce dasatinib metabolism.

What to do

Monitor for dasatinib toxicity such as myelosuppression and fluid retention; no empirical dose change is required.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Desogestrel-ethinyl estradiol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Desogestrel-ethinyl estradiol?

MediHelp rates the interaction as minor. Dasatinib and Desogestrel-ethinyl estradiol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dasatinib is a CYP3A4 substrate and ethinyl estradiol is a weak CYP3A4 inhibitor, so a small rise in dasatinib exposure is conceivable. Clinical significance is likely modest. Dasatinib is also teratogenic, so reliable contraception remains important.

How serious is the interaction between Dasatinib and Desogestrel-ethinyl estradiol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for dasatinib toxicity such as myelosuppression and fluid retention; no empirical dose change is required.

What other medicines interact with Desogestrel-ethinyl estradiol?

MediHelp also lists interactions of Desogestrel-ethinyl estradiol with, for example, Fezolinetant, Aminocaproic acid, Amobarbital. The full list is on the Desogestrel-ethinyl estradiol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in